The objective of the proposed project is to develop a database that allows FDA reviewers and stakeholders to share and retrieve bcos along with related files and technical specification for storing,…

Ended Definitive Contract Awarded Last action

Contract number
75F40119C10136
Awardee
Awarding agency
Obligated
$2,218,450

Award facts

Opportunity
  • FDABAA1900123 Solicitation number
Contract value 100% obligated
$2,218,449.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Washington, DC 20052, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 · Deobligation/closeout -$20,535
Other Administrative Action P00005 · No cost modification to change the period of performance end date to september 22, 2025. $0
Exercise an Option P00004 $504,747
Exercise an Option P00003 $507,376
Exercise an Option P00002 $507,376
Other Administrative Action P00001 $0
Original award $719,486

About this award

The Food and Drug Administration awarded a definitive contract to George Washington University for development of a database to enable FDA reviewers and stakeholders to share, retrieve, and access Biologics Cost of Goods Sold (BCOS) data and related technical specifications on September 20, 2019, with a ceiling value of $2,218,449.72 under cost-no-fee pricing.

Place of performance is Washington, DC. The contract reached ultimate completion on September 22, 2025.

Service Contract Inventory reporting shows the award delivered 1.7 to 2.9 FTEs annually across FY2021–FY2024, with government-invoiced labor totaling $2.172 million over that span. Derived hourly rates ranged from $68.98/hr in FY2021 to $125.49/hr in FY2022, stabilizing around $115–$118/hr in FY2023–FY2024. The university self-performed all hours; no subcontractors were reported. FY2025 invoicing ($29 thousand, 0.1 FTEs) reflects contract closeout activity ahead of the September 2025 completion date.

Description

The objective of the proposed project is to develop a database that allows FDA reviewers and stakeholders to share and retrieve bcos along with related files and technical specification for storing, accessing, and retrieving bcos in the database and

Quick answers

Who was awarded contract 75F40119C10136?

75F40119C10136 was awarded to George Washington University (The) by Food and Drug Administration (Department of Health and Human Services) on September 20, 2019.

How much is contract 75F40119C10136 worth?

The government has obligated $2,218,450 on 75F40119C10136.

Was contract 75F40119C10136 competed?

The extent of competition for 75F40119C10136 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award